Bijoy Hans Ltd (ARVAYA) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Bijoy Hans Ltd on NSE and BSE, with an AI summary of each filing.
The Company has completed the acquisition of Sushodha Institute of Gastroenterology Private Limited (SIGPL) having 1,84,374 equity shares constituting 100% of the equity share capital of ....
Others (Uncategorized) · 02 Nov 2026, 12:24 am
Arvaya Healthcare Completes 100% Acquisition of Sushodha Institute of Gastroenterology Arvaya Healthcare Limited has completed the acquisition of a 100% equity stake in Sushodha Institute of Gastroenterology Private Limited (SIGPL) on 1st Nov'26, following its earlier intimation on 24th Oct'26. The transaction involved acquiring 1,84,374 equity shares of SIGPL. Effective 1st Nov'26, SIGPL has officially become a wholly-owned subsidiary of Arvaya Healthcare.
Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve 1. To consider and approve ....
Intimation · 29 Oct 2026, 10:38 pm
Arvaya Healthcare Board to Consider Rights Issue and Related Party Transactions Arvaya Healthcare Limited's Board of Directors is scheduled to meet on 4th Nov'26 to review and approve key capital and corporate actions. The agenda includes evaluating the Draft Letter of Offer (DLOF) for its proposed Rights Issue, finalizing the issue's objects, and determining the deployment and utilization of proceeds. Additionally, the board will consider and approve proposed material related-party transactions, subject to required Audit Committee recommendations and shareholder approvals.
Disclosure under Regulation 7(2)(a) of SEBI (PIT) Regulations 2015 received from Mr. Bidari Kotresh Anilkumar Executive Director
Others (Uncategorized) · 25 Oct 2026, 12:00 am
Arvaya Healthcare Director Acquires Shares via Preferential Allotment Arvaya Healthcare Limited disclosed that Executive Director Bidari Kotresh Anilkumar acquired 591,129 equity shares via a preferential allotment (share swap) on 24th Oct'26. Following the transaction, his shareholding increased from 1,720,873 equity shares (3.58%) to 2,312,002 equity shares (4.45%).
Allotment of 38,71,854 fully paid Equity Shares of Rs.10/-each at an issue price of Rs.40/- per equity share including a premium of Rs.30/- per equity share aggregating to Rs. 15,48,74,160/- ....
Others (Uncategorized) · 24 Oct 2026, 11:31 pm
Arvaya Healthcare Approves ₹15.49 Crore Preferential Share Swap Allotment Arvaya Healthcare Limited's board approved the preferential allotment of 38,71,854 fully paid equity shares of ₹10 face value at an issue price of ₹40 per share (including a ₹30 premium), aggregating to ₹15.49 crore on 24th Oct'26. The allotment was made to 47 non-promoter shareholders of Sushodha Institute of Gastroenterology Private Limited on a share swap basis for consideration other than cash. Consequently, paid-up equity capital increased from ₹48.02 crore (4,80,21,857 shares) to ₹51.89 crore (5,18,93,711 shares), subject to standard regulatory lock-in requirements.
Allotment of 38,71,854 (Thirty Eight Lakh Seventy One Thousand Eight Hundred Fifty Four) fully paid-up equity shares of face value of ?10/- (Rupees Ten Only) each ('Equity Shares') at an ....
Outcome · 24 Oct 2026, 11:19 pm
Arvaya Healthcare Approves ₹15.49 Crore Preferential Share Swap Allotment On 24th Oct'26, Arvaya Healthcare approved the preferential allotment of 38,71,854 equity shares at ₹40 per share (face value ₹10, premium ₹30), aggregating to ₹15.49 crore, to shareholders of Sushodha Institute of Gastroenterology on a share swap basis. Consequently, the company's paid-up equity capital expanded from ₹48.02 crore (4,80,21,857 shares) to ₹51.89 crore (5,18,93,711 shares). The newly issued shares carry pari-passu rights with existing equity and remain subject to statutory lock-in requirements pending listing approvals.
Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/10/2026 ,inter alia, to consider and approve The allotment of 38,71,854 ....
Intimation · 17 Oct 2026, 11:32 pm
Arvaya Healthcare Board to Consider Preferential Share Allotment for Non-Cash Consideration Arvaya Healthcare Limited (formerly Bijoy Hans Limited) announced that a meeting of its Board of Directors is scheduled for 24th Oct'26. The board will inter-alia consider and approve the preferential allotment of 3,871,854 equity shares to the shareholders of Sushodha Institute of Gastroenterology Private Limited (SIGPL) for consideration other than cash.
The Company received In-Principal approval dated 12th October 2026 on Preferential basis of 3871854 equity shares.
Others (Uncategorized) · 13 Oct 2026, 12:12 am
Arvaya Healthcare Secures BSE In-Principle Approval for Preferential Equity Issue Arvaya Healthcare Limited received in-principle approval from BSE on 12th Oct'26 for the preferential issuance of 3,871,854 equity shares at an issue price of Rs. 40 per share (face value Rs. 10 each). The allotment is designated for non-promoters pursuant to a share swap arrangement. The approval is subject to statutory compliances under SEBI ICDR and LODR Regulations, including mandatory lock-in guidelines and submission of a listing application within 20 days post-allotment.
Declaration of Remote e-voting and e-voting at AGM results along with Scrutinizers Report.
Annual General Meeting · 23 Sept 2026, 8:36 pm
Disclosure under Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulations 2015 for the proceedings of 41st Annual General Meeting of the Company held through VC mode.
Annual General Meeting · 22 Sept 2026, 3:36 am
The certificate of Incorporation was received by the company.
Others (Uncategorized) · 20 Sept 2026, 12:41 am
Arvaya Healthcare Incorporates Wholly-Owned Subsidiary for Insurance Broking Business Arvaya Healthcare Limited has incorporated a wholly-owned subsidiary, Arvaya Insurance Broking Private Limited, receiving its Certificate of Incorporation on 17th Sep'26. The new entity will operate in the insurance broking sector as a Direct Insurance Broker across General and Life Insurance, having secured a No Objection Certificate from the IRDA. Arvaya Healthcare acquired a 100% equity stake for an aggregate cash consideration of Rs. 80.00 lakh, subscribing to 8,00,000 equity shares priced at Rs. 10 each.
Intimation about Web link for AGM of the company to be held on 21st September, 2026 at 3:00 p.m.
Annual General Meeting · 29 Aug 2026, 2:57 am
41st Annual report for year 2025-26
Others (Uncategorized) · 29 Aug 2026, 2:47 am
Notice of AGM to be held on 21st September 2026 at 3:00 p.m.
Annual General Meeting · 29 Aug 2026, 2:40 am
Approval of Material Related Party Transaction
Outcome · 26 Aug 2026, 10:25 pm
Arvaya Healthcare Approves Acquisition of IP Portfolio for up to ₹10 Crore Arvaya Healthcare's board on 26th Aug'26 approved a Material Related Party Transaction to acquire the Copyright and Intellectual Property (IP) portfolio of DEFIB INSTITUTE OF HEALTH SOLUTIONS LLP for a consideration not exceeding ₹10 crore. This acquisition focuses solely on specific IP assets and is not a full business purchase. The transaction will be funded from the proceeds of a rights issue and is subject to regulatory and shareholder approvals. The Audit Committee reviewed and recommended the draft agreement and valuation report to the board.
Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/08/2026 ,inter alia, to consider and approve Material Related Party Transaction ....
Intimation · 22 Aug 2026, 3:31 am
Arvaya Healthcare Board to Consider Acquisition via Rights Issue Proceeds Arvaya Healthcare's Board of Directors will meet on 26 Aug'26 to consider and approve a related party transaction with Navahmedi Solution Private Limited. The agenda includes the acquisition of Navahmedi's business undertaking via a slump sale, encompassing its intellectual property, assets, and liabilities. This proposed acquisition is intended to be funded using proceeds from a rights issue. The company, formerly known as Bijoy Hans Limited, announced this meeting to the Bombay Stock Exchange on 21 Aug'26.
Proposed incorporation of Wholly Owned Private Limited Company.
Others (Uncategorized) · 13 Aug 2026, 2:17 am
Arvaya Healthcare to Form a Wholly-Owned Insurance Broking Subsidiary Arvaya Healthcare's Board approved the incorporation of a wholly-owned subsidiary in India on 12 Aug'26. The new entity will operate in the insurance broking services sector. Arvaya will own 100% of the shareholding, making the new firm a related party. The move is subject to regulatory approval from the Insurance Regulatory Development Authority of India (IRDA). The name, cost of subscription, and specific consideration details for the new subsidiary are yet to be finalized. This marks a strategic diversification into financial services.
Statement of Deviation for the quarter ended 30 June 2026 is not applicable.
Others (Uncategorized) · 13 Aug 2026, 1:37 am
Arvaya Healthcare: No Deviation in Fund Utilisation for Q1 FY27 Arvaya Healthcare Limited (BSE: 524723) informed exchanges on 12th Aug'26 that the Statement of Deviation or Variation in the utilisation of funds is not applicable to the company for the quarter ended 30th Jun'26. This filing is pursuant to Regulation 32 of SEBI (LODR) Regulations, 2015. The declaration confirms no reportable variance in the use of funds raised against stated objectives for the period.
Unaudited Financial Results for the first quarter ended 30 June 2026.
Financial Result · 13 Aug 2026, 1:31 am
Arvaya Healthcare Reports Q1 FY27 Results and Approves Material Related Party Transactions Arvaya Healthcare reported Q1 FY27 consolidated results with revenue from operations at ₹2,990.67 lacs and PAT at ₹53.23 lacs. This compares to a Q1 FY26 loss of ₹25.29 lacs. Basic EPS for the quarter was ₹0.08. On 12 Aug'26, the board approved material related party transactions for FY27, totaling ₹210 crores with promoter group entities and ₹200 crores with subsidiaries and other related parties. The board also approved Q1 financials, the incorporation of a wholly-owned subsidiary for insurance broking, and various board-level appointments.
Outcome of the Board Meeting as per attached PDF.
Outcome · 13 Aug 2026, 1:21 am
Bijoy Hans Ltd - Financial Result for the Quarter ended 30th Jun'26 (Consolidated, INR Lacs) ■ Revenue: 2,991 (+228.2% QoQ) ■ EBITDA: 236 (Loss to Profit YoY | +154.3% QoQ) ■ EBITDA Margin (%): 7.9 (-229 bps QoQ) ■ PAT: 39.9 (Loss to Profit YoY | -68.6% QoQ) ■ EPS (INR): 0.08 (Loss to Profit YoY | -93.6% QoQ)
Arvaya Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Unaudited Financial Results ....
Intimation · 12 Aug 2026, 5:30 am
Arvaya Healthcare Board Meeting Scheduled for Aug'26 Financial Results Arvaya Healthcare's Board of Directors will meet on 12th Aug'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter ended 30th Jun'26. Other key agenda items include approving material related party transactions and several appointments. Specifically, the board will consider a new Non-Executive Independent Director and two new directors for its wholly-owned subsidiaries. The trading window for company securities has been closed from 1st Jul'26 and will reopen 48 hours after the results are declared.
The Board has approved shifting of RO from Assam to Maharashtra, Subject to regulatory Approvals.
Others (Uncategorized) · 11 Jul 2026, 8:28 pm
Arvaya Healthcare Approves Acquisition via Share Swap and ₹210 Crore Rights Issue Arvaya Healthcare board approved on 11 Jul'26 the 100% acquisition of Sushodha Institute of Gastroenterology (SIGPL) for ₹15.49 Cr. The consideration will be discharged via a preferential issue of 38.72 lakh equity shares at ₹40 per share. SIGPL reported a turnover of ₹8.99 Cr for FY26. Additionally, the board approved a rights issue to raise up to ₹210 Cr and a change of its registered office from Assam to Maharashtra. The acquisition is expected to be completed within 12 months.
Board Meeting approved the acquisition of the SIGPL.
Others (Uncategorized) · 11 Jul 2026, 8:26 pm
Arvaya Healthcare Approves Acquisition, Rights Issue, and Preferential Allotment On 11-Jul'26, Arvaya Healthcare's board approved acquiring 100% of Sushodha Institute of Gastroenterology (SIGPL) for Rs. 15.49 Cr. The deal will be settled via a preferential issue of 38.72 lakh equity shares at Rs. 40 per share. SIGPL's turnover was Rs. 8.99 Cr for FY25-26. The board also approved a separate Rights Issue to raise up to Rs. 210 Cr and a change of its registered office from Assam to Maharashtra, all subject to shareholder and regulatory approvals.
Board has approved preferential allotment in meeting dated 11 July 2026
Others (Uncategorized) · 11 Jul 2026, 8:23 pm
Arvaya Healthcare Approves Acquisition, Rights Issue, and Preferential Allotment On 11 Jul'26, Arvaya Healthcare's board approved acquiring 100% of Sushodha Institute of Gastroenterology for Rs. 15.49 Cr. The deal will be settled via a preferential issue of 38.72 lakh equity shares at Rs. 40 each (including a Rs. 30 premium). The target entity, SIGPL, reported a turnover of Rs. 8.99 Cr for FY26. Additionally, the board approved a Rights Issue to raise up to Rs. 210 Cr and a change in its registered office from Assam to Maharashtra.
The board has approved resolution regarding Preferential Allotment and Rights Issue.
Others (Uncategorized) · 11 Jul 2026, 8:18 pm
Arvaya Healthcare To Acquire SIGPL; Approves Rs. 210 Crore Rights Issue Arvaya Healthcare's board approved on Jul 11, '26, the 100% acquisition of Sushodha Institute of Gastroenterology (SIGPL) for Rs. 15.49 Cr. The consideration will be discharged via a preferential issue of 38.72 lakh equity shares at Rs. 40 each (including a Rs. 30 premium). SIGPL's turnover for 2025-26 was Rs. 8.99 Cr. Additionally, the board approved a rights issue to raise up to Rs. 210 Cr and the relocation of its registered office from Assam to Maharashtra.
As per attached Outcome.
Outcome · 11 Jul 2026, 8:13 pm
Arvaya Healthcare to Acquire SIGPL via Share Swap and Raise Funds On 11 Jul'26, Arvaya Healthcare approved the 100% acquisition of Sushodha Institute of Gastroenterology (SIGPL) for ₹15.49 Cr. The consideration will be discharged via a preferential issue of 38.72 lakh equity shares at ₹40 per share. SIGPL reported a turnover of ₹8.99 Cr for FY25-26. Additionally, the board approved a Rights Issue to raise up to ₹210 Cr and a change of its registered office from Assam to Maharashtra, subject to approvals. This acquisition aims to expand Arvaya's hospital footprint and enhance revenue streams.